Cancer researchers don’t want a ‘cure’, they would lose billions
The war on cancer began nearly half a century ago, and yet, not much has really changed. Hundreds of billions of dollars have been spent on cancer research and development, so you’d think by now they’d have come up with better, more effective treatments, wouldn’t you? Look at the immense developments that have been made in other forms of technology — and in less time! Smartphones, anyone?
All of the money spent and research conducted has had a very little impact on cancer incidence; modest reductions in cancer deaths are largely attributed to earlier detection, which in turn increases five-year survival rates. The five-year survival rate is modern medicine’s most favored measurement of success, though, in terms of overall lifespan, five years is really a drop in the bucket for most people.
Of course, there are reasons why cancer research has been begrudgingly slow to make progress. First and foremost, most research directs itself away from the true primary cause of cancer: exposure to toxins. Decades ago, this could have been attributed to a lack of knowledge, but today it is clear that there are reasons behind this diversion.
Two primary reasons are to protect corporate interests and those who produce and sell toxins, as well as mainstream medicine’s greed. Cancer is a multi-billion dollar industry, so why would they sacrifice their virtually boundless income just to heal people?
By continuing to keep the focus off of what causes cancer (toxins), endless cancer “research” prevents toxin-producing industries and toxin-containing products from being scrutinized. The American Cancer Society itself states, “Only about 5% to 10% of all cancers result directly from gene defects (called mutations) inherited from a parent.” This would suggest that the amount of cancer research that is done on inherited cancers is relatively disproportionate. It should also suggest that the main cause of cancer probably isn’t genetic.
The Truth About Cancer reports, “In 2010, the President’s Cancer Panel provided strong confirmation that exposure to toxic chemicals is an important and under-recognized risk factor for cancer. Right on cue, the industry-influenced American Cancer Society attempted to refute the panel’s conclusions.” Along with other organizations, like the National Cancer Institute, they continue to perpetuate the myth that the primary cause of cancer is actually genetics. In doing so, these phony, corporate-funded mouthpieces are essentially saying that toxins are less likely to harm us than the DNA making up our own bodies.
The fact remains that corporate interests, even within the cancer industry itself, far outweigh the quest to find a cure. In addition to protecting those who donate the most money to their organizations, much of the medical industry revolves around cancer treatment and repeat customers. Oncologists, nurses, technicians, drug manufacturers, and many other players all rely on the constant flow of cancer to keep their income on the up and up.
The real question we should be asking is not, “Why isn’t there a cure?” Instead, we should be asking ourselves, “Why are we surprised?”